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Preeclampsia, a human pregnancy speciﬁc disorder is characterized by an anti-angiogenic state. As
hydrogen sulﬁde (H2S) has pro-angiogenic and anti-oxidative characteristics, we hypothesized that H2S
levels could play a role in the pathogenesis of preeclampsia and studied the placental expression of the
H2S-producing enzymes cystathionine-g-lyase (CSE) and cystathionine-b-synthase (CBS). CBS and CSE
protein are expressed in the fetal-placental endothelium and CBS only in Hofbauer cells. CBS mRNA
expression is decreased (p ¼ 0.002) in early-onset preeclampsia, while CSE mRNA is unchanged. Thus,
down regulation of CBS during early-onset preeclampsia may result in less H2S-production and may aid
in the anti-angiogenic state.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Preeclampsia (PE), a human pregnancy speciﬁc disorder, is
characterized by placental ischemia and maternal endothelial
dysfunction [1]. The poorly perfused and ischemic placenta releases
excess amounts of anti-angiogenic factors causing generalized
endothelial damage [2,3].
Hydrogen sulﬁde (H2S) is produced from the amino acid L-
cysteine by two pyridoxal 50 phosphate-dependent enzymes cys-
tathionine-g-lyase (CSE) and cystathionine-b-synthase (CBS). H2S
induces vasorelaxation by opening ATP-sensitive K-channels in
smooth muscle cells and up regulates vascular endothelial growth
factor [4,5]. Furthermore, H2S also has antioxidant capacity by
direct scavenging of nitrogen or reactive oxygen species [6]. CBS
and CSE are down regulated in several cardiovascular and pulmo-
nary diseases [7]. Exogenous H2S (NaHS) administration is
proposed as a novel therapy in animal models of cardiovascular and
ischemic diseases [7,8]. CBS is also an important enzyme in the
homocysteine pathway, since homocysteine is converted toþ31 50 3619107.
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a moderate increase of homocysteine which associated with
blunted endothelial-dependent relaxation in arteries [9].
We hypothesized that H2S, because of its pro-angiogenic and
anti-oxidative characteristics and the involvement of CBS in
homocysteine degradation, might play a role in the pathogenesis of
PE. The aim of the present study was to identify and compare the
expression and localization of CBS and CSE in placental tissue from
both normotensive and early- and late-onset PE.2. Methods
Placental biopsies were obtained from patients (n ¼ 36) with early-onset PE,
late-onset PE and mode of delivery matched healthy pregnant controls after
informed consent. The local UMCG Medical Ethical Committee approved the study.
PE was deﬁned according to the standards of the International Society for the Study
of Hypertension in Pregnancy: diastolic blood pressure of >90 mmHg and
proteinuria 300mg/24 h [10]. PE present before 34weeks of gestationwas deﬁned
as early-onset, these patients delivered by Cesarean section. Intra-uterine growth
restriction (IUGR) was deﬁned as birth weight under the tenth percentile (Table 1).
As previously described, placental cryosections were stained [11] with mouse
monoclonal antibodies against CSE (1:100, donated by Dr. N. Nishi, Kagawa Medical
School, Japan) and CBS (1:250, Abnova, Tapei, Taiwan). Primary antibody was
replaced by PBS in negative controls. For immunoﬂuorensence double staining,
CD31 (1:100, SigmaeAldrich, St. Louis, MO) was used.
For real time RT-PCR, RNA was isolated from several parts of the placenta,
pooled, and puriﬁed as previously described [12]. We analyzed mRNA expression of
CBS and CSE using Assay-on-Demand Gene Expression (Applied Biosystems, USA).
Table 1
Clinical characteristics of pregnant women with early- and late-onset preeclampsia and mode of delivery matched controls.
Delivery by Cesarean section Spontaneous delivery
Control
pregnancy
Early-onset
preeclampsia
Control
pregnancy
Late-onset
preeclampsia
Number 9 10 8 9
Age (years) 33 (26e35) 31 (25e26) 27 (27e37) 30 (26e33)
Gestational age at delivery
(weeks þ days)
38 þ 6 (38 þ 6e39 þ 3) 28 þ 6 (27 þ 5e30 þ 3)** 39 þ 3 (38 þ 5e41 þ 0) 38 þ 1 (37 þ 0e39 þ 3)U
Systolic blood pressure
(mmHg)
132 (125e147) 178 (166e190)* 120 (118e120) 155 (150e163)UU
Diastolic blood pressure
(mmHg)
80 (80e85) 110 (110e115)** 76 (70e80) 97 (92e105)UU
Proteinuria (grams/24 h) 0 3.0 (0.9e4.9)** 0 0.8 (0.7e0.8)UU
Birth weight (grams) 3880 (3610e4085) 933 (713e1103)** 3390 (3180e3700) 2770 (2569e3071)U
HELLP syndrome 0 0 0 0
IUGR 0 2 (20) 0 1 (11)
Data are expressed as median (interquartile range) and numbers (%).
For statistical analysis ManneWhitney U test and Fisher exact test were used.
*p < 0.05, **p < 0.001, when compared to healthy pregnancy with delivery by Cesarean section.
Up < 0.05, UUp < 0.001, when compared to healthy pregnancy with spontaneously delivery.
Fig. 1. Placental expression of CBS and CSEmRNA and protein in healthy pregnancy and
pregnancy complicated byearly- and late-onset preeclampsia A. CBSmRNAexpression is
down regulated in the early-onset preeclampsia group, compared to the mode for
delivery matched group (delivery by Cesarean section). No differences were observed in
CBS mRNA expression in the late-onset PE group or in CSE mRNA expression in all four
groups. There was as well no difference in mRNA between the late- and early-onset PE
groups of both enzymes. B. Quantitativewestern blot analysis showed a signiﬁcant down
regulation of both CBS and CSE in all spontaneous delivery placentae, compared to the
Cesarean groups. No differences were observed in expression of both enzymes between
both PE groups and mode of delivery matched controls. Bands 1e4 show representative
western blots for CBS in placentae derived from respectively Cesarean controls, early-
onset PE, spontaneous controls and late-onset PE. Bands 5e8 show representative
western blots for CSE in the same groups. For all ﬁgures, median an interquartile range is
given. For statistical analysis, ManneWhitney U test was used. Quantiﬁcation of protein
expression was performed by measuring band intensity using ImageJ software.
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gene, the expression of this gene was constant over the four study groups [13].
Total proteins from placental biopsies were extracted and western analysis was
performed according to published procedures [14,15]. CBS and CSE monoclonal
antibodies (Abnova) were used at 1:500 dilution.
3. Results and discussion
The major ﬁnding of this study is that CBS mRNA expression is
signiﬁcantly down regulated in placental villous tissue derived
from pregnancies complicated by early-onset PE when comparing
to mode of delivery matched controls (Fig. 1A). Furthermore, we
demonstrated that CBS and CSE are mainly localized in the endo-
thelium in the fetal vessels from the chorionic- and stem-villi
(Fig. 2A). The endothelial origin of both enzymes is conﬁrmed by
double staining with CD31 (Fig. 2B). Hofbauer cells express CBS
(Fig. 2A). There were no differences in CBS/CSE in protein expres-
sion between PE and delivery matched controls (Fig. 1B). However,
CBS/CSE protein expression was signiﬁcantly down regulated in all
placentae after spontaneous delivery compared to Cesarean
delivery (Fig. 1B).
Although protein expression of CBS and CSE was not affected by
PE, we found a down regulation of mRNA of CBS in early-onset PE.
This discrepancy between mRNA and protein expression is
remarkable, but has been reported previously [16]. In ischemic
brain tissue, decrease in mRNA corresponded to decreased CBS-
activity and H2S-production, while protein levels did not [16].
Since protein levels do not imply protein-activities, we did not
evaluate CSE- and CBS-activity or H2S-production. However, Patel
et al. showed that H2S is endogenously produced in the placenta,
production rate was increased under low-oxygen levels [17].
Another study conﬁrmed placental catalytic CBS-activity by con-
verting homocysteine [18]. So far, in PE no CBS- and CSE-activity or
H2S-production is reported. Therefore, the exact role of endoge-
nous H2S in PE needs to be elucidated.
Differential CBS mRNA expression may be gestation related, as
has been previously documented for other genes, however no
differences in CBS mRNA expression measured in ﬁrst-trimester
and term human placentae were reported [19]. For late-onset PE,
placental CBS mRNA expression is not altered compared to healthy
pregnancies (Fig. 1A). This is in line with the growing evidence that
there are differences between the pathophysiology of early- and
late-onset PE [20]. In our total study group, 3 patients with
a pregnancy complicated by IUGR were present. The data of these
patients with respect to mRNA and protein expression ﬁtted well
within their study groups.
Fig. 2. Placental localization of CBS and CSE protein expression in healthy pregnancy IHC and IF staining was performed on all samples of the 4 groups (n ¼ 36). No differences in
localization were observed between groups; therefore only representative cryostat sections of control placental villous tissue stained for CBS (A, C, F) and CSE (B, E) are shown.
Positive staining is shown in fetal endothelial cells in chorionic villi (long arrow), fetal endothelial cells in stem villi (closed short arrow) and in Hofbauer cells (arrow-head).
Syncytio- and cytotrophoblasts are negative (open short arrow). No positive staining is observed in the negative control, in which the primary antibody was replaced by PBS (D). For
the IF staining (E, F), nuclear staining (DAPI) is shown in blue, CD31 protein is shown in red, CSE and CBS protein in green, and co-localization of CD31 with CBS or CSE in white. IF
staining conﬁrmed the endothelial expression of both CSE and CBS protein. All images were taken at the same exposure and with a magniﬁcation of 20 (A, B, D, E, F) or 40 (C).
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down regulated in control and PE placentae after spontaneous
delivery compared to Cesarean delivery. This is in line with a recent
report of down regulation of the enzymes and reduced H2S-
production in themyometriumduring labor [21]. Increased turnover
of the enzymes could be involved in transition of the labor process.
The fetal endothelial expression of CBS and CSE is in accord with
the expressions in other organs [22]. Moreover, we showed
expression of CBS by Hofbauer cells. Hofbauer cells or fetal tissue
macrophages are placental immune cells; several studies suggest
that Hofbauer cells play a direct role in placental vasculogenesis
[23]. Although CSE has been shown to be expressed by macro-
phages [24], the expression of CBS by macrophages has not been
reported. The expression of CBS by Hofbauer cells may be in line
with the role of these cells in vasculogenesis.In conclusion, the present study provides novel insights into the
expression of H2S-producing enzymes during normal and PE.
Future studies will compare the placental CBS/CSE-activity and
H2S-production in pregnancies and explore the possible thera-
peutic role of H2S during PE.
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